Related Experiment Video

Updated: Apr 26, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.7K

Going further in the knowledge of Yondelis®; what's new in clinical trials?

Jean-Yves Blay1

  • 1Department of Medical Oncology, Centre Léon Bérard, 28 Rue Laennec, 69008 Lyon, France. jean-yves.blay@lyon.unicancer.fr.

Future Oncology (London, England)
|July 23, 2014
PubMed

Insights

Trabectedin offers treatment options for advanced soft tissue sarcoma (STS) patients. Research continually refines its use, exploring first-line and combination therapies for better outcomes in STS treatment.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Trabectedin is approved for advanced soft tissue sarcoma (STS) after standard chemotherapy failure or as a first-line option for specific patients.
  • Clinical investigations since 1995 have provided insights into trabectedin's efficacy and clinical profile.

Purpose of the Study:

  • To review clinical trial results of trabectedin in advanced STS.
  • To optimize the clinical use of trabectedin through ongoing research.

Main Methods:

  • Review of retrospective analyses and Phase II studies.
  • Analysis of data from randomized studies focusing on first-line use, combination regimens, and specific STS subtypes.

Main Results:

  • Established activity and unique clinical profile of trabectedin in advanced STS.
  • Ongoing research areas include first-line treatment, combination therapies, and activity in specific sarcoma subtypes.

Conclusions:

  • Trabectedin plays a defined role in advanced STS treatment.
  • Continued research aims to refine trabectedin's optimal application in clinical practice for STS therapy.
Keywords:
first-line chemotherapyrandomized controlled trialssoft tissue sarcomatrabectedin

More Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

29.3K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

20.5K

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K